• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

TLR expression and induction of type I and type III interferons in primary airway epithelial cells

tetano

Editor, Senior Moderator
J Virol. 2013 Jan 9. [Epub ahead of print]
TLR expression and induction of type I and type III interferons in primary airway epithelial cells.
Ioannidis I, Ye F, McNally B, Willette M, Fla?o E.
Source

Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.
Abstract

Interferons (IFNs) are a critical component of the first line of antiviral defense. The activation of Toll-like receptors (TLRs) expressed by dendritic cells triggers different signaling cascades that result in the production of large amounts of IFNs. However, the functional consequences of TLR activation and differential IFN production in specific cell populations other than antigen presenting cells are not fully elucidated yet. In this study, we investigated TLR expression and polarization in airway epithelial cells (AECs), and the consequences of TLR agonist stimulation for the production of type I (IFNα/β) and type III (IFNλ) IFNs. Our results show that the pattern of expression and polarization of all TLRs in primary AEC cultures mirrors that of the human airways ex-vivo, and that is receptor-specific. The anti-viral TLRs (TLR3, TLR7 and TLR9) are mostly expressed on the apical cell surface of epithelial cells in the human trachea and in primary polarized AECs. Type III IFN is the predominant IFN produced by the airway epithelium, and TLR3 is the only TLR that mediates IFN production by AECs, while all TLR agonists tested are capable of inducing AEC activation and IL-8 production. In response to influenza virus infection, AECs can produce IFNλ in an IFNAR- and STAT1-independent manner. Our results emphasize the importance of using primary well-differentiated AECs to study TLR and anti-viral responses, and provide further insight in the regulation of IFN production during the anti-viral response of the lung epithelium.

PMID:
23302870
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23302870
 
Back
Top Bottom